ASPM and endometrial cancer: Furthermore, a cross comparison of common DEGs across the three datasets revealed that TOP2A, ASPM, FOXL2 and EFEMP1 were potential biomarkers for distinguishing endometrial cancer, and this was significantly associated with the survival ratios among patients.